- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
40
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
40 companies
Revvity
Market Cap: US$11.3b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$91.82
7D
-1.3%
1Y
-7.6%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.17
7D
5.1%
1Y
-34.3%
Amgen
Market Cap: US$152.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$277.29
7D
-1.5%
1Y
5.5%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥125.1b
Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.
600436
CN¥207.38
7D
1.2%
1Y
-8.3%